CobotSys

CobotSys (库柏特) develops AI robotics systems for China’s healthcare sector, combining 3D vision, force control, and deep learning technologies. Founded in Wuhan’s Optics Valley in 2016, the company expanded from industrial robotics into specialized medical applications. Its intelligent ultrasound robot received NMPA Class III certification through the innovative medical device green channel — a pathway through which, per the company, no other ultrasound robot has been cleared in China to date.

Company Overview

CobotSys emerged from the convergence of AI and robotics expertise, initially developing the CobotSys intelligent robot operating system for industrial applications. The company pivoted to focus on healthcare in 2019 after recognizing the potential to apply its core technologies—3D intelligent recognition, force control systems, and robotic manipulation—to solve critical medical challenges.

The transition proved strategic. By 2021, CobotSys had deployed its zero-contact smart pharmacy solution at Wuhan Union Hospital’s Jinyin Lake Campus, marking the first fully intelligent pharmacy system in a tertiary hospital in Hubei Province. The company has since been recognized as a provincial-level “Little Giant” specialized enterprise and included in China’s potential unicorn enterprise list.

CobotSys has secured five rounds of funding totaling approximately CNY 400 million from investors including GGV Capital, Matrix Partners China, Bluerun Ventures, Frees Fund, and CICC Qizhi Fund.

Core Products

Intelligent Ultrasound Robot Scanning Diagnosis System

The company’s flagship medical device received NMPA Class III certification in December 2023 (Registration No. 20233061635), becoming the only ultrasound robot in China to pass through the innovative medical device approval pathway. The system integrates collaborative robot arms with AI-powered image analysis to enable both remote-controlled and autonomous ultrasound examinations.

The robot can scan seven organ systems including thyroid, carotid artery, liver, gallbladder, pancreas, spleen, and kidney. Clinical validation across more than 30 hospitals demonstrated 97% concordance with physician diagnoses.

Smart Pharmacy Solutions

CobotSys offers over 40 pharmacy automation products covering outpatient dispensing, inpatient pharmacy operations, IV admixture preparation, and consumable management. Key components include intelligent dispensing-replenishment integrated machines, smart secondary storage units, visual verification systems, and high-speed dual-mode dispensers.

The company’s compliance-based unit-dose packaging robot broke the monopoly of overseas manufacturers in this segment, offering comparable technology at lower cost.

Hospital Logistics Robot

The in-hospital logistics robot system handles material transportation throughout medical facilities, integrating with the company’s broader smart hospital ecosystem.

Technology & Innovation

CobotSys’s proprietary operating system — combining 3D vision, force control, and imitation learning — underpins the ultrasound robot the company cites as the sole platform cleared through NMPA’s innovative device green channel in this category.

CobotSys built its medical robotics capabilities on the proprietary CobotSys operating system, which serves as the “brain” connecting vision, manipulation, and decision-making modules. The platform incorporates:

• 3D vision and intelligent recognition
• Flexible grasping with force feedback
• Robot teleoperation and imitation learning
• Multi-modal data processing
• Real-time force-position control

For the ultrasound robot, the company partnered with Elite Robot to integrate collaborative arms with proprietary AI algorithms for autonomous scanning and diagnosis. The system processes ultrasound images in real-time, automatically identifying suspicious lesions and generating diagnostic reports within seconds.

Market Presence

CobotSys solutions have been deployed in over 100 hospitals across more than 20 provinces, including prestigious institutions such as PLA General Hospital, Peking University Third Hospital, Tongji Hospital, Union Hospital, and Zhongshan Hospital.

The company established a manufacturing facility in Xiantao High-tech Zone (Hubei) that began production in April 2025, with monthly order volumes exceeding CNY 20 million and projected annual revenue of CNY 180 million.

CobotSys was selected for the Ministry of Industry and Information Technology’s list of 25 excellent robot application scenarios in the medical field in 2021.

Key Milestones

• 2016: Company founded in Wuhan Optics Valley
• 2019: Strategic pivot to focus on healthcare applications
• 2020: Smart pharmacy solutions deployed at Wuhan Union Hospital and Tongji Hospital
• 2021: Zero-contact pharmacy at Union Hospital Jinyin Lake Campus; selected for MIIT robot application excellence list; awarded provincial “Little Giant” status
• 2022: First-generation remote ultrasound robot developed
• 2023: Intelligent Ultrasound Robot received NMPA Class III certification (20233061635); second-generation autonomous ultrasound robot launched
• 2024: Multi-organ autonomous ultrasound robot entered NMPA innovative device green channel
• 2025: Hubei manufacturing facility operational; monthly orders exceed CNY 20 million

Frequently Asked Questions

What products does CobotSys offer?

CobotSys develops three main product lines: the Intelligent Ultrasound Robot Scanning Diagnosis System (NMPA Class III certified), smart pharmacy automation solutions (over 40 products), and hospital logistics robots. All products are built on the company’s proprietary CobotSys intelligent robot operating system.

Is CobotSys publicly traded?

CobotSys is not currently publicly traded. The company has been listed as a key reserve enterprise for IPO in Hubei Province and included in China’s potential unicorn enterprise list. It has completed five rounds of funding totaling approximately CNY 400 million.

What makes CobotSys ultrasound robot unique?

The CobotSys Intelligent Ultrasound Robot is the only product in China to receive approval through NMPA’s innovative medical device green channel for ultrasound robotics. It offers both remote-controlled operation (allowing specialists to examine patients across any distance) and fully autonomous scanning with AI-powered diagnosis, achieving 97% concordance with physician assessments.